Key Coverage Facts Coverage varies significantly by plan even within the same insurer, different employer plans have different formularies Coverage varies by employer size: 16% of mid-size employers (200-999 workers), 30% of large employers (1,000-4,999), and 43% of very large employers (5,000+) cover GLP-1 medications for weight loss [1] More than 88% of patients with coverage face prior authorization or other restrictionsyour doctor must get approval before you can fill it Medicare Part D excludes weight loss drugs by federal statute (may cover for CV risk reduction indication) About a dozen state Medicaid programs cover GLP-1s for obesity, though policies are evolving [2] Coverage by Plan Type Already denied
Mounjaro is FDA-approved for controlling blood sugar in adults with type 2 diabetes, like Ozempic and Rybelsus
Weight regain is possible if healthy habits are not maintained
The short answer is that tirzepatide (the active ingredient in Mounjaro and Zepbound) appears to be slightly more effective than semaglutide (the active ingredient in Wegovy and Ozempic) in studies both for weight loss and diabetes
According to the drug label, Mounjaro is most likely to reduce birth control efficacy after the first dose, with this potential side effect diminishing over time
